Loading...
Channel Therapeutics Corporation
PTHS•NYSE
Healthcare
Biotechnology
$25.30
$8.84(53.64%)
Channel Therapeutics Corporation (PTHS) AI-Powered Stock Analysis
See how Channel Therapeutics Corporation scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
